Market Access/ News/ News Motif pummelled as FDA asks for more data on antibiotic Phil Taylor ABSSSI, fda, iclaprim, Motif Bio 0 Comment Shares in UK biotech Motif Bio fell more than 50% after its much-delayed antibiotic was held up at Share X Motif pummelled as FDA asks for more data on antibiotic https://pharmaphorum.com/news/motif-pummelled-as-fda-asks-for-more-data-on-antibiotic/
